These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23437201)

  • 1. Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate.
    Roedder S; Kimura N; Okamura H; Hsieh SC; Gong Y; Sarwal MM
    PLoS One; 2013; 8(2):e56657. PubMed ID: 23437201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.
    Gu G; Huang Y; Wu C; Guo Z; Ma Y; Xia Q; Awasthi A; He X
    Transplantation; 2017 Jan; 101(1):83-91. PubMed ID: 27575691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection.
    Matignon M; Aissat A; Canoui-Poitrine F; Grondin C; Pilon C; Desvaux D; Saadoun D; Barathon Q; Garrido M; Audard V; Rémy P; Lang P; Cohen J; Grimbert P
    Am J Transplant; 2015 Oct; 15(10):2718-25. PubMed ID: 25989263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.
    Alfaro R; Martínez-Banaclocha H; Llorente S; Jimenez-Coll V; Galián JA; Botella C; Moya-Quiles MR; Parrado A; Muro-Perez M; Minguela A; Legaz I; Muro M
    Front Immunol; 2021; 12():800968. PubMed ID: 34975915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key driver genes as potential therapeutic targets in renal allograft rejection.
    Yi Z; Keung KL; Li L; Hu M; Lu B; Nicholson L; Jimenez-Vera E; Menon MC; Wei C; Alexander S; Murphy B; O'Connell PJ; Zhang W
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation.
    Khatri P; Roedder S; Kimura N; De Vusser K; Morgan AA; Gong Y; Fischbein MP; Robbins RC; Naesens M; Butte AJ; Sarwal MM
    J Exp Med; 2013 Oct; 210(11):2205-21. PubMed ID: 24127489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble FGL2 induced by tumor necrosis factor-α and interferon-γ in CD4+ T cells through MAPK pathway in human renal allograft acute rejection.
    Zhao Z; Wang L; Yang C; Zhao T; Li L; Hu L; Wu D; Rong R; Xu M; Zhu T
    J Surg Res; 2013 Oct; 184(2):1114-22. PubMed ID: 23664593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytokine profiles and their relevance to rejection following renal transplantation.
    Kaminski ER; Kaminski A; Bending MR; Chang R; Heads A; Szydlo RM; Pereira RS
    Transplantation; 1995 Oct; 60(7):703-6. PubMed ID: 7570980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study.
    Millán O; Rafael-Valdivia L; San Segundo D; Boix F; Castro-Panete MJ; López-Hoyos M; Muro M; Valero-Hervás D; Rimola A; Navasa M; Muñoz P; Miras M; Andrés A; Guirado L; Pascual J; Brunet M
    Clin Immunol; 2014 Oct; 154(2):141-54. PubMed ID: 25088788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy.
    Mao Y; Wang M; Zhou Q; Jin J; Wang Y; Peng W; Wu J; Shou Z; Chen J
    J Clin Immunol; 2011 Jun; 31(3):414-8. PubMed ID: 21191639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model.
    Erickson LM; Pan F; Ebbs A; Kobayashi M; Jiang H
    Transplantation; 2003 Aug; 76(3):582-8. PubMed ID: 12923448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
    Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
    Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
    Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
    Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological features of renal allograft biopsies in ABO minor-mismatched kidney transplantation.
    Shimizu T; Tanabe K; Tokumoto T; Shimmura H; Ishikawa N; Ishida H; Toma H; Kawaguchi H; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2003; 17 Suppl 10():9-13. PubMed ID: 12823250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C; Zucker K; Asthana D; Carreno M; Viciana AL; Ruiz P; Esquenazi V; Nery J; Burke G; Miller J
    Hum Immunol; 1996 Jan; 45(1):1-12. PubMed ID: 8655354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients.
    Burke GW; Ciancio G; Cirocco R; Markou M; Coker D; Roth D; Nery J; Esquenazi V; Miller J
    Transplantation; 1996 Apr; 61(7):1114-6. PubMed ID: 8623196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.
    Sarwal M; Chua MS; Kambham N; Hsieh SC; Satterwhite T; Masek M; Salvatierra O
    N Engl J Med; 2003 Jul; 349(2):125-38. PubMed ID: 12853585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.